Search

請注意 ⚠️ 旅英人員及留學生接種疫苗最新指引 (包括已接種各種大陸及台灣產疫苗)

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1009174/COVID-19_vaccination_programme_guidance_for_healthcare_workers_6_August_2021_v3.10.pdf

根據英國衛生部八月六號最新發布的指引第十五頁及附錄一,建議旅英各國人員及廣大留學生根據身體健康狀況和年齡儘快接種英國現已批准的三種疫苗包括德國輝瑞生物科技新冠病毒疫苗,美國莫德納新冠病毒疫苗,英國阿利斯康-牛津新冠病毒疫苗。


特別提醒⏰ 兩岸四地已經接種一劑或者二劑中國或台灣當地產疫苗,在接種八週後需儘快聯繫在英註冊的家庭醫師諮詢重新接種英國現有疫苗。


根據最新指引已經接種國外獲批疫苗(並在英國獲批清單中)第一劑,需根據疫苗類別推薦英國已經批准類似疫苗補種一劑,如果國外批准的疫苗不在英國已經批准的清單中,建議根據身體健康需要重新開始接種兩劑新疫苗。英國現階段沒有任何滅活新冠病毒疫苗獲得批准,因此來英工作學習的人員如果已經接種一劑或者兩劑中國國藥集團新冠病毒疫苗或者中國科興公司新冠病毒疫苗需儘快聯繫家庭醫生根據自己身體和年齡選擇三種在英國已經批准的疫苗重新接種。如果來英人員已經接種一劑中國康希諾生物公司新冠病毒疫苗,可以遵醫囑選擇相類似的阿利斯康-牛津新冠病毒疫苗補種一劑疫苗。現階段暫不建議已經接種三劑的來英人員補種或者重新接種。如果您有任何有關疫苗的問題,請向家庭醫生或者111電話熱線諮詢。


Page 15 -- Individuals who received COVID vaccination overseas

If a person has received a first dose of a COVID-19 vaccine overseas that is also available in the UK, they should receive the same vaccine for their second dose. If the vaccine they received for their first dose is not available in the UK, the most similar alternative should be offered (see table in Appendix 1). If the vaccine received overseas is not listed in the table, a full course of the appropriate vaccine recommended for the individual in the UK (which may depend on their age) should be given. The recommendations in this table will be reviewed regularly as more vaccines and information about the efficacy of these vaccines becomes available.

The various groups of vaccines are:

  • Adenovirus (ChAdOx) vector: AstraZeneca, Covishield

  • mRNA: Pfizer, Moderna

  • whole inactivated Coronavirus: Sinopharm, Sinovac, Covaxin The other adenovirus-based vaccines (Janssen, Sputnik, CanSinoBio) use different vectors and so are not immunologically the same as either the AstraZeneca or Covishield adenovirus vector vaccines. However, as they, and the Novavax vaccine, are all based on spike protein, the vaccine course can be completed with any of the locally available vaccines as appropriate for the individual’s age.

Please refer to appendix 1page 40 and 41 for alternative vaccines selection.


28 views0 comments